Pentamidine

DB00738ApprovedInvestigationalSmall moleculeAntiprotozoals

Pentamidine is an antifungal agent used to treat Pneumocystis pneumonia in patients infected with HIV. It may cause diabetes mellitus, central nervous system damage, and other toxic effects.

Chemical structure of Pentamidine
Mechanism
Curator reviewed
Primary indication
For the treatment of pneumonia due to Pneumocystis carinii.Curator reviewed · 5 structured indications
Formula / weight
C19H24N4O2 · 340.4195 g/mol (avg)
First approval
Canada, 2000 · United States, 1994
Code names
MB 800 · RP 2512
Brand names
  • Nebupent
  • Pentam

Resolves to

Structure
InChIKeyXDRYMKDFEDOLFX-UHFFFAOYSA-NSMILESNC(=N)C1=CC=C(OCCCCCOC2=CC=C(C=C2)C(N)=N)C=C1
Transporters

What you can answer from here — as of September 23, 2026

14Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
1,893Drug interactionsStructured to mechanism, not free text
Sign in
27Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
19Marketed productsAcross 7 countries and 13 labellers
Sign in
1ATC codeIncluding every combination product, plus 27 drug categories
Sign in
31+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Pentamidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account